Amider Pharmaceuticals Private Limited
Amider Pharmaceuticals Private Limited is a Private Non-govt company company incorporated in 2021 and based in Rajasthan, India. It was founded by Raj and Vanita. Amider Pharmaceuticals Private Limited operates in Pharmaceuticals & Chemicals (NIC 24290) with authorized capital of ₹1.00 L and paid-up capital of ₹1.00 L. For 2021-22, the company reported revenue of ₹0 and a net loss of ₹236. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Amider Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +38d | filed |
| MGT-7 | FY2024-25 | 20 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 24 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 20 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Amider Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 395489624 | HDFC Bank Ltd(Bank) | ₹18.85 Cr | 04 Jul 2022 | Open |
| 199201483 | Axis Bank Ltd(Bank) | ₹3.71 Cr | 12 Mar 2020 | Open |
| 883836283 | Axis Bank Ltd(Bank) | ₹17.12 Cr | 04 Jul 2019 | Open |
| 160928687 | ICICI Bank Ltd(Bank) | ₹22.82 Cr | 27 Jan 2022 | Open |
| 688858117 | HDFC Bank Ltd(Bank) | ₹18.66 Cr | 27 Jan 2019 | Open |
Charge IDs, lenders & amounts for Amider Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2021-22 | — |
Detailed Financials
1 FYs| Line item | 2021-22 |
|---|---|
| Income statement | |
| Revenue from operations | |
| Other income | |
| Total income | |
| Total expenses | |
| Profit before tax | |
| Profit / (Loss) after tax | |
| Balance sheet | |
| Equity / Net worth | |
| Borrowings | |
| Current liabilities | |
| Total liabilities | |
| Current assets | |
| Cash & equivalents | |
| Total assets | |
| Employees | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹49.88 Cr | +28.0% | -0.8% | +0.3% |
| Profit after Tax | ₹7.76 Cr | -2.2% | -0.5% | +15.9% |
| Net Worth | ₹30.09 Cr | +7.5% | +14.7% | +16.9% |
| Employees | 108 | +13.3% | +24.9% | +15.7% |
Audited financials & ratios for Amider Pharmaceuticals Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2021-22 | — | — | -0.24% | -0.24% | 1.00 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 48,77,115 | 64.57% |
| Institutional Investors | 2 | 3,37,924 | 4.47% |
| Public & Others | 44 | 23,38,190 | 30.96% |
Promoter, institutional & public holding for Amider Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
44 peersEvents & timeline
3External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.